Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 4 , ISSUE 2 ( July-December, 2015 ) > List of Articles

Original Article

Efficacy of six minute walk test in improving exercise tolerance in South Indian Patients with Idiopathic Pulmonary Fibrosis

Thekkinkathil Mohankumar, T.S. Muthukumar

Keywords : Idiopathic pulmonary fibrosis, interstitial lung disease, minimal clinically important difference, six minute walk test

Citation Information : Mohankumar T, Muthukumar T. Efficacy of six minute walk test in improving exercise tolerance in South Indian Patients with Idiopathic Pulmonary Fibrosis. Indian J Respir Care 2015; 4 (2):664-668.

DOI: 10.5005/jp-journals-11010-04212

License: NA

Published Online: 02-12-2022

Copyright Statement:  NA


Introduction: The six minute walk test (6MWT) is a practical and reliable measure of exercise tolerance that is widely used to assess the functional status of the patients with a variety of cardiac and pulmonary diseases, including heart failure, pulmonary hypertension, and Chronic Obstructive Pulmonary Disease (COPD). Objective: To evaluate the reliability validity and responsiveness of the six minute walk test and to measure the minimal clinically important difference (MCID) in South Indian IPF patients. Methods: The study population consisted of 30 patients diagnosed as IPF. Six minute walk test distance and other parameters were measured at baseline and at 18 week interval using a standard protocol. Correlation coefficients were used to evaluate the association between six minute walk distance and measures of dyspnea using Borg Scale rate of perceived exertion and Quality of Life questionnaire using St George Respiratory Questionnaire. The distribution based method was used to quantify the MCID. Results: The relationship between 6MWD with dyspnea and St George Respiratory Questionnaire showed good reliability (coefficient = 0.69 p<0.05). There was strong correlation between increase in 6MWD and decrease in Borg Scale of rate of perceived exertion and also decreased St George Respiratory Questionnaire indicating improvement in quality of life. The calculated MCID was 15 m. The decline in 6MWD indicated the prognosis of the disease. Conclusions: The six minute walk test is a clinically helpful measure of status of the disease and the prognosis in South Indian patients with IPF.

  1. du Bois RM, Weycker D et al. Six minute walk test in Idiopathic pulmonary fibrosis Test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011: 183:1231-7.
  2. Subhash H S, Ashwin I, Solomon SK, David T, Cherian AM. A comparative study on Idiopathic pulmonary fibrosis and secondary diffuse parenchymal lung disease. Indian J Med Sci 2004;58: 185-90.
  3. Latsi PI, du Bois RM, Micholson AG, et al. Fibrotic idiopathic interstitial pneumonia:the prognostic value of longituidinal functional trends. Am J Respir Crit Care Med 2003; 168:531-7.
  4. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J 1986; 292: 653-5.
  5. Cahalin LP, Mathier MA, Semigran MJ et al. the six minute walk test predicts peak oxygen uptake and survival in patients with heart failure. Chest 1996;110:325-32.
  6. Gomberg-Maitland M, Huo D et al. Creation of a model comparing 6 minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. J Heart Lung Transplant 2007;26: 732-8.
  7. Guyatt GH, Pugsley SQ et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-22.
  8. Baughman RP, Sparkman BK, Lower EE. Six minute walk test and health assessment in sarcoidosis. Chest 2007;132:207-13.
  9. Jasechke R, Singer J, Guyatt GH. Measurement of health status, ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
  10. American Thoracic Society, European Respiratory Society, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161:646-64.
  11. American Thoracic Society, European Respiratory Society, ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 166: 277-304.
  12. American Thoracic society statement: Guidelines for the six minute walk test. Am J Respir Crit Care Med 2002;166: 111-7.
  13. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment if health related quality of life in patients with interstitial lung disease. Chest 1999; 116:1175-82.
  14. Eaton T, Young P Miline D, Wells AU. Six minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 1150-7.
  15. Caminati A, Bianchi A, et al. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009; 103:117-23.
  16. Redelmeier DA, Bayoumi AM, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-minute walk distance in chronic lung disease patients. Am J Respir Crit Care Med 1997;155: 1278-2.
  17. Holland AE, Hill CJ, Conron M, Munro P et al. Small changes in six minute walk distance are important in diffuse parenchymal lung disease. Respir Med 2009; 103:1430-5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.